Glucocorticoid receptor in multiple myeloma
- 1 July 1987
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 39 (1) , 54-59
- https://doi.org/10.1111/j.1600-0609.1987.tb00164.x
Abstract
Glucocorticoid receptor levels of myeloma cells were quantitated in 7 patients with multiple myeloma. In 4 patients, glucocorticoid receptor levels were less than 10 fmol/106 cells. In 3 patients, receptor levels were from 17.6 to 21.4 fmol/106 cells. We further examined the correlation between glucocorticoid receptor levels and effect of dexamethasone on 14C-thymidine incorporation and cell viability using 2 myeloma cell lines, OPM-1 and OPM-2, established from a patient with multiple myeloma. Glucocorticoid receptor levels of OPM-1 and OPM-2 were 8.5 fmol/106 cells and 63.2 fmol/106 cells, respectivley. The sensitivity of OPM-1 to dexamethasone in these studies was lower than that of OPM-2. These results suggest the possibility that the low level of glucocorticoid receptor in myeloma cells may be important for predicting a poor response to glucocorticoid therapy.Keywords
This publication has 10 references indexed in Scilit:
- Two distinct human myeloma cell lines originating from one patient with myelomaInternational Journal of Cancer, 1985
- Prednisone pulse therapy for refractory myelomaBlood, 1983
- PREDNISONE PULSE THERAPY FOR REFRACTORY MYELOMA1983
- Clinical implications of glucocorticoid receptor studies in childhood acute lymphoblastic leukemiaBlood, 1980
- CLINICAL IMPLICATIONS OF GLUCOCORTICOID RECEPTOR STUDIES IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA1980
- Mechanisms of corticosteroid action on lymphocyte subpopulationsCellular Immunology, 1980
- Glucocorticoid Receptor in Circulating Mononuclear LeukocytesEndocrinology, 1979
- Glucocorticoid Receptors in Purified Subpopulations of Human Peripheral Blood LymphocytesThe Journal of Immunology, 1977
- Melphalan and prednisone: An effective combination for the treatment of multiple myelomaThe American Journal of Medicine, 1973
- Treatment for Multiple MyelomaJAMA, 1969